Citigroup has received an average recommendation of "Moderate Buy" from 20 research firms covering the stock. Of those, 14 have issued buy endorsements while six recommend holding the shares. Analysts’ average 12-month price objective stands at $124.65, reflecting expectations for mid-single-digit upside over the coming year.

Several high-profile banks have adjusted their views. HSBC reiterated its buy rating and established an $87.00 target. JPMorgan Chase upgraded the shares from neutral to overweight, raising its target from $107.00 to $124.00. Oppenheimer lifted its target from $141.00 to $144.00 while maintaining an outperform stance. Wolfe Research reaffirmed its outperform rating with a $141.00 objective, and DBS Bank downgraded its recommendation from moderate buy to hold.

In its latest quarter, Citigroup reported earnings of $1.81 per share, topping consensus estimates by $0.16. Revenue reached $19.87 billion, missing the $20.99 billion analyst consensus, but still marking a 2.1% year-over-year gain. Net margin was 8.5%, while return on equity registered 8.28%. Analysts now project full-year earnings of $7.53 per share.

The firm declared a quarterly dividend of $0.60, equivalent to a $2.40 annual payout and a 2.0% yield, with a payout ratio of 34.43%. Institutional activity has been robust: Wolff Wiese Magana increased its stake by 87.6% to 257 shares, Dunhill Financial added 92.2% to reach 319 shares, and GoalVest Advisory expanded by 57.2% to 393 shares. Overall, institutional investors hold roughly 71.7% of the outstanding shares.